Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03590171 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.
Track this trial| NCT Number | NCT03590171 |
| Lead Sponsor | Charite University, Berlin, Germany
Collaborators: Australian & New Zealand Children's Haematology/Oncology Group, St. Anna Kinderkrebsforschung, CCRI (co-sponsor, Austria), European Organisation for Research and Treatment of Cancer - EORTC, University Hospital, Motol, Rigshospitalet, Denmark, Turku University Central Hospital (co-sponsor, Finland), Centre Hospitalier Universitaire de Nice, Our Lady's Chilrden's Hospital (Co-Sponsor Ireland), Tel Aviv Sourasky Medical Centre (Co-Sponsor Israel), Ospedale Pediatrico Bambino (co-sponsor, Italy), Prinses Máxima Centrum (Co-Sponsor Netherlands), Oslo University Hospital (co-sponsor, Norway), Wroclaw Medical University, Instituto Português de Oncologia de Lisboa (co-sponsor, Portugal), Karolinska University Hospital Stockholm (co-sponsor, Sweden), Spanish Society of Pediatric Hematology and Oncology (SEHOP) (Co-Sponsor Spain), University Children's Hospital, Zurich, Manchester University NHS Foundation Trust |
| Conditions | Acute Lymphoblastic Leukemia (ALL) |
| Enrollment | 250 participants |
| Start Date | 2017-09-01 |
| Primary Completion | 2027-12-31 (estimated) |
| Study Completion | 2027-12-31 (estimated) |
| Updated on ClinicalTrials.gov | 2026-03-17 |